Health TrialsbyHealthPanel

Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

ConditionsHemianopsiaVirtual RealityVisual RehabilitationPediatric Brain Tumor
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age10-40
SponsorInstitut National de la Santé Et de la Recherche Médicale, France

About this trial

Evaluate the efficiency of audiovisual stimulation in virtual reality for improving the visual perception of children, adolescents, and young adults with hemianopia resulting from pediatric brain tumors. These individuals can lose up to 50% of their visual field, significantly impacting their independence, mobility, and daily lives.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male and Female

10 - 40 years old

Diagnosed hemianopsia (>12 months)

History of diagnosis brain tumour

Disqualifiers

Age< 10 years old of > 40 years old

Ocular disease

Inability to perform during testing or training

3 consecutive VRISE scores < 25 at inclusion

Trial design

Design model

Parallel

Treatments tested in this trial

  • Visual Stimulation

    Device

    Our audiovisual stimulation procedure IVR, called 3D-MOT, was encoded using the the 3D Unity programming platform and deployed in HMDs with built-in head/eye tracking. We implemented the multiple object tracking (MOT) paradigm, developed in the 80's to study visual attention in humans, and added correlated spatial sound.

  • standard of care

    Other intervention

    During this phase, the patients will be at home without a headset and will not be exposed to an audio-visual stimulation task in virtual reality.

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: ControlOther 2 interventions
Group B: InterventionOther 2 interventions

Trial outcomes

Primary outcomes

1

Visual field perimetry measured using the Esterman binocular field test

Increase at least 3 points in the number of points perceived in the blind field at the Esterman binocular field test after intervention (8 weeks) when compared to baseline and between control and interventional group.

Time frame
From enrollment to the end of follow up period at 6 months

Secondary outcomes

1

Participant-reported a vision impairment specific quality of life questionnaire: Impact of Vision Impairment Questionnaire (IVI).

Questionnaire will be provided and compared at baseline and after intervention ( 8 weeks) and between control and interventional group. A diminution of the mean score above 0.3-0.5 point will be consider as an amelioration of quality of life impacted by vision impairment.

Time frame
From enrollment to the end of follow up period at 6 months
2

Reading speed - Minnesota Low Vision Reading (MNREAD) test

Reading speed will be assessed and compared at baseline and after intervention (8 weeks) and between control and interventional groups. An increase in reading speed of 8.6 words per minute on the Minnesota Low Vision Reading (MNREAD) test will be considered an improvement in the variable.

Time frame
From enrollment to the end of follow up period at 6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Institut National de la Santé Et de la Recherche Médicale, France

Lead sponsor

Fight Kids Cancer

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: